Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...

Shares of Upstream Bio, Inc. (NASDAQ:UPB – Get Free Report) were down 3% during mid-day trading on Thursday . The stock traded as low as $18.15 and last traded at $18.81. Approximately 4,187 shares ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.